By Julie A. Steinberg, Bloomberg BNA
GlaxoSmithKline LLC can’t escape a $3 million verdict for the widow of a Chicago attorney who committed suicide days after starting a generic equivalent of the company’s antidepressant Paxil.
Evidence at trial supported the jury’s finding that the warning was misleading and didn’t fully apprise Stewart Dolin’s physicians about the risk of adult suicide, the U.S. District Court for the Northern District of Illinois said Sept. 14.
And the court found no basis to set aside the jury’s finding that paroxetine, the active ingredient in the drug, caused Dolin’s death.
Dolin, a partner at ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.